img

Global Dry Eye Disease Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dry Eye Disease Sales Market Report 2024

Market Analysis and InsightsGlobal Dry Eye Disease Market
Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
Due to the COVID-19 pandemic, the global Dry Eye Disease market size is estimated to be worth US$ 2397.5 million in 2024 and is forecast to a readjusted size of US$ 2949.6 million by 2034 with a CAGR of 2.6% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Artificial Tears accounting for % of the Dry Eye Disease global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
The United States Dry Eye Disease market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Dry Eye Disease include Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma and Johnson & Johnson, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Dry Eye Disease Scope and Market Size
The global Dry Eye Disease market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Dry Eye Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other

Segment by Application


Hospital
Drug Stores
Online Pharmacies
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions



By Company


Santen Pharma
Novartis
Llergan
Takeda
TRB Chemedica
Sun Pharmaceutical
Senju Pharmaceutical
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI
Altacor
Valeant Pharmaceuticals
United Laboratories
Jianfeng Group
Eusan GMBH

Table of Content

1 Dry Eye Disease Market Overview
1.1 Dry Eye Disease Product Scope
1.2 Dry Eye Disease Segment by Type
1.2.1 Global Dry Eye Disease Sales by Type (2018 & 2024 & 2034)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Dry Eye Disease Segment by Application
1.3.1 Global Dry Eye Disease Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Dry Eye Disease Market Estimates and Forecasts (2018-2034)
1.4.1 Global Dry Eye Disease Market Size in Value Growth Rate (2018-2034)
1.4.2 Global Dry Eye Disease Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global Dry Eye Disease Price Trends (2018-2034)
2 Dry Eye Disease Estimates and Forecasts by Region
2.1 Global Dry Eye Disease Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global Dry Eye Disease Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Dry Eye Disease Sales Market Share by Region (2018-2023)
2.2.2 Global Dry Eye Disease Revenue Market Share by Region (2018-2023)
2.3 Global Dry Eye Disease Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global Dry Eye Disease Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global Dry Eye Disease Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dry Eye Disease Estimates and Projections (2018-2034)
2.4.2 Europe Dry Eye Disease Estimates and Projections (2018-2034)
2.4.3 China Dry Eye Disease Estimates and Projections (2018-2034)
2.4.4 Japan Dry Eye Disease Estimates and Projections (2018-2034)
2.4.5 Southeast Asia Dry Eye Disease Estimates and Projections (2018-2034)
2.4.6 India Dry Eye Disease Estimates and Projections (2018-2034)
3 Global Dry Eye Disease Competition Landscape by Players
3.1 Global Top Dry Eye Disease Players by Sales (2018-2023)
3.2 Global Top Dry Eye Disease Players by Revenue (2018-2023)
3.3 Global Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Disease as of 2024)
3.4 Global Dry Eye Disease Average Price by Company (2018-2023)
3.5 Manufacturers Dry Eye Disease Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Dry Eye Disease Market Size by Type
4.1 Global Dry Eye Disease Historic Market Review by Type (2018-2023)
4.1.1 Global Dry Eye Disease Sales by Type (2018-2023)
4.1.2 Global Dry Eye Disease Revenue by Type (2018-2023)
4.1.3 Global Dry Eye Disease Price by Type (2018-2023)
4.2 Global Dry Eye Disease Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global Dry Eye Disease Sales Forecast by Type (2024-2034)
4.2.2 Global Dry Eye Disease Revenue Forecast by Type (2024-2034)
4.2.3 Global Dry Eye Disease Price Forecast by Type (2024-2034)
5 Global Dry Eye Disease Market Size by Application
5.1 Global Dry Eye Disease Historic Market Review by Application (2018-2023)
5.1.1 Global Dry Eye Disease Sales by Application (2018-2023)
5.1.2 Global Dry Eye Disease Revenue by Application (2018-2023)
5.1.3 Global Dry Eye Disease Price by Application (2018-2023)
5.2 Global Dry Eye Disease Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global Dry Eye Disease Sales Forecast by Application (2024-2034)
5.2.2 Global Dry Eye Disease Revenue Forecast by Application (2024-2034)
5.2.3 Global Dry Eye Disease Price Forecast by Application (2024-2034)
6 United States Dry Eye Disease Market Facts & Figures
6.1 United States Dry Eye Disease Sales by Company
6.1.1 United States Dry Eye Disease Sales by Company (2018-2023)
6.1.2 United States Dry Eye Disease Revenue by Company (2018-2023)
6.2 United States Dry Eye Disease Sales Breakdown by Type
6.2.1 United States Dry Eye Disease Sales Breakdown by Type (2018-2023)
6.2.2 United States Dry Eye Disease Sales Breakdown by Type (2024-2034)
6.3 United States Dry Eye Disease Sales Breakdown by Application
6.3.1 United States Dry Eye Disease Sales Breakdown by Application (2018-2023)
6.3.2 United States Dry Eye Disease Sales Breakdown by Application (2024-2034)
7 Europe Dry Eye Disease Market Facts & Figures
7.1 Europe Dry Eye Disease Sales by Company
7.1.1 Europe Dry Eye Disease Sales by Company (2018-2023)
7.1.2 Europe Dry Eye Disease Revenue by Company (2018-2023)
7.2 Europe Dry Eye Disease Sales Breakdown by Type
7.2.1 Europe Dry Eye Disease Sales Breakdown by Type (2018-2023)
7.2.2 Europe Dry Eye Disease Sales Breakdown by Type (2024-2034)
7.3 Europe Dry Eye Disease Sales Breakdown by Application
7.3.1 Europe Dry Eye Disease Sales Breakdown by Application (2018-2023)
7.3.2 Europe Dry Eye Disease Sales Breakdown by Application (2024-2034)
8 China Dry Eye Disease Market Facts & Figures
8.1 China Dry Eye Disease Sales by Company
8.1.1 China Dry Eye Disease Sales by Company (2018-2023)
8.1.2 China Dry Eye Disease Revenue by Company (2018-2023)
8.2 China Dry Eye Disease Sales Breakdown by Type
8.2.1 China Dry Eye Disease Sales Breakdown by Type (2018-2023)
8.2.2 China Dry Eye Disease Sales Breakdown by Type (2024-2034)
8.3 China Dry Eye Disease Sales Breakdown by Application
8.3.1 China Dry Eye Disease Sales Breakdown by Application (2018-2023)
8.3.2 China Dry Eye Disease Sales Breakdown by Application (2024-2034)
9 Japan Dry Eye Disease Market Facts & Figures
9.1 Japan Dry Eye Disease Sales by Company
9.1.1 Japan Dry Eye Disease Sales by Company (2018-2023)
9.1.2 Japan Dry Eye Disease Revenue by Company (2018-2023)
9.2 Japan Dry Eye Disease Sales Breakdown by Type
9.2.1 Japan Dry Eye Disease Sales Breakdown by Type (2018-2023)
9.2.2 Japan Dry Eye Disease Sales Breakdown by Type (2024-2034)
9.3 Japan Dry Eye Disease Sales Breakdown by Application
9.3.1 Japan Dry Eye Disease Sales Breakdown by Application (2018-2023)
9.3.2 Japan Dry Eye Disease Sales Breakdown by Application (2024-2034)
10 Southeast Asia Dry Eye Disease Market Facts & Figures
10.1 Southeast Asia Dry Eye Disease Sales by Company
10.1.1 Southeast Asia Dry Eye Disease Sales by Company (2018-2023)
10.1.2 Southeast Asia Dry Eye Disease Revenue by Company (2018-2023)
10.2 Southeast Asia Dry Eye Disease Sales Breakdown by Type
10.2.1 Southeast Asia Dry Eye Disease Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Dry Eye Disease Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia Dry Eye Disease Sales Breakdown by Application
10.3.1 Southeast Asia Dry Eye Disease Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Dry Eye Disease Sales Breakdown by Application (2024-2034)
11 India Dry Eye Disease Market Facts & Figures
11.1 India Dry Eye Disease Sales by Company
11.1.1 India Dry Eye Disease Sales by Company (2018-2023)
11.1.2 India Dry Eye Disease Revenue by Company (2018-2023)
11.2 India Dry Eye Disease Sales Breakdown by Type
11.2.1 India Dry Eye Disease Sales Breakdown by Type (2018-2023)
11.2.2 India Dry Eye Disease Sales Breakdown by Type (2024-2034)
11.3 India Dry Eye Disease Sales Breakdown by Application
11.3.1 India Dry Eye Disease Sales Breakdown by Application (2018-2023)
11.3.2 India Dry Eye Disease Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in Dry Eye Disease Business
12.1 Santen Pharma
12.1.1 Santen Pharma Corporation Information
12.1.2 Santen Pharma Business Overview
12.1.3 Santen Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Santen Pharma Dry Eye Disease Products Offered
12.1.5 Santen Pharma Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Novartis Dry Eye Disease Products Offered
12.2.5 Novartis Recent Development
12.3 Llergan
12.3.1 Llergan Corporation Information
12.3.2 Llergan Business Overview
12.3.3 Llergan Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Llergan Dry Eye Disease Products Offered
12.3.5 Llergan Recent Development
12.4 Takeda
12.4.1 Takeda Corporation Information
12.4.2 Takeda Business Overview
12.4.3 Takeda Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Takeda Dry Eye Disease Products Offered
12.4.5 Takeda Recent Development
12.5 TRB Chemedica
12.5.1 TRB Chemedica Corporation Information
12.5.2 TRB Chemedica Business Overview
12.5.3 TRB Chemedica Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.5.4 TRB Chemedica Dry Eye Disease Products Offered
12.5.5 TRB Chemedica Recent Development
12.6 Sun Pharmaceutical
12.6.1 Sun Pharmaceutical Corporation Information
12.6.2 Sun Pharmaceutical Business Overview
12.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Sun Pharmaceutical Dry Eye Disease Products Offered
12.6.5 Sun Pharmaceutical Recent Development
12.7 Senju Pharmaceutical
12.7.1 Senju Pharmaceutical Corporation Information
12.7.2 Senju Pharmaceutical Business Overview
12.7.3 Senju Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Senju Pharmaceutical Dry Eye Disease Products Offered
12.7.5 Senju Pharmaceutical Recent Development
12.8 Sentiss Pharma
12.8.1 Sentiss Pharma Corporation Information
12.8.2 Sentiss Pharma Business Overview
12.8.3 Sentiss Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Sentiss Pharma Dry Eye Disease Products Offered
12.8.5 Sentiss Pharma Recent Development
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Corporation Information
12.9.2 Johnson & Johnson Business Overview
12.9.3 Johnson & Johnson Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Johnson & Johnson Dry Eye Disease Products Offered
12.9.5 Johnson & Johnson Recent Development
12.10 Otsuka
12.10.1 Otsuka Corporation Information
12.10.2 Otsuka Business Overview
12.10.3 Otsuka Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Otsuka Dry Eye Disease Products Offered
12.10.5 Otsuka Recent Development
12.11 Mitotech
12.11.1 Mitotech Corporation Information
12.11.2 Mitotech Business Overview
12.11.3 Mitotech Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Mitotech Dry Eye Disease Products Offered
12.11.5 Mitotech Recent Development
12.12 FCI
12.12.1 FCI Corporation Information
12.12.2 FCI Business Overview
12.12.3 FCI Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.12.4 FCI Dry Eye Disease Products Offered
12.12.5 FCI Recent Development
12.13 Altacor
12.13.1 Altacor Corporation Information
12.13.2 Altacor Business Overview
12.13.3 Altacor Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Altacor Dry Eye Disease Products Offered
12.13.5 Altacor Recent Development
12.14 Valeant Pharmaceuticals
12.14.1 Valeant Pharmaceuticals Corporation Information
12.14.2 Valeant Pharmaceuticals Business Overview
12.14.3 Valeant Pharmaceuticals Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.14.4 Valeant Pharmaceuticals Dry Eye Disease Products Offered
12.14.5 Valeant Pharmaceuticals Recent Development
12.15 United Laboratories
12.15.1 United Laboratories Corporation Information
12.15.2 United Laboratories Business Overview
12.15.3 United Laboratories Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.15.4 United Laboratories Dry Eye Disease Products Offered
12.15.5 United Laboratories Recent Development
12.16 Jianfeng Group
12.16.1 Jianfeng Group Corporation Information
12.16.2 Jianfeng Group Business Overview
12.16.3 Jianfeng Group Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.16.4 Jianfeng Group Dry Eye Disease Products Offered
12.16.5 Jianfeng Group Recent Development
12.17 Eusan GMBH
12.17.1 Eusan GMBH Corporation Information
12.17.2 Eusan GMBH Business Overview
12.17.3 Eusan GMBH Dry Eye Disease Sales, Revenue and Gross Margin (2018-2023)
12.17.4 Eusan GMBH Dry Eye Disease Products Offered
12.17.5 Eusan GMBH Recent Development
13 Dry Eye Disease Manufacturing Cost Analysis
13.1 Dry Eye Disease Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dry Eye Disease
13.4 Dry Eye Disease Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dry Eye Disease Distributors List
14.3 Dry Eye Disease Customers
15 Market Dynamics
15.1 Dry Eye Disease Industry Trends
15.2 Dry Eye Disease Market Drivers
15.3 Dry Eye Disease Market Challenges
15.4 Dry Eye Disease Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dry Eye Disease Sales (US$ Million) Growth Rate by Type (2018 & 2024 & 2034)
Table 2. Global Dry Eye Disease Sales ((US$ Million)) Comparison by Application (2018 & 2024 & 2034)
Table 3. Global Dry Eye Disease Market Size (US$ Million) by Region: 2018 VS 2024 VS 2034
Table 4. Global Dry Eye Disease Sales (Kg) by Region (2018-2023)
Table 5. Global Dry Eye Disease Sales Market Share by Region (2018-2023)
Table 6. Global Dry Eye Disease Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Dry Eye Disease Revenue Share by Region (2018-2023)
Table 8. Global Dry Eye Disease Sales (Kg) Forecast by Region (2024-2034)
Table 9. Global Dry Eye Disease Sales Market Share Forecast by Region (2024-2034)
Table 10. Global Dry Eye Disease Revenue (US$ Million) Forecast by Region (2024-2034)
Table 11. Global Dry Eye Disease Revenue Share Forecast by Region (2024-2034)
Table 12. Global Dry Eye Disease Sales by Company (Kg) & (2018-2023)
Table 13. Global Dry Eye Disease Sales Share by Company (2018-2023)
Table 14. Global Dry Eye Disease Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Dry Eye Disease Revenue Share by Company (2018-2023)
Table 16. Global Dry Eye Disease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Disease as of 2024)
Table 17. Global Market Dry Eye Disease Average Price by Company (USD/Kg) & (2018-2023)
Table 18. Manufacturers Dry Eye Disease Manufacturing Sites and Area Served
Table 19. Manufacturers Dry Eye Disease Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 22. Global Dry Eye Disease Sales Share by Type (2018-2023)
Table 23. Global Dry Eye Disease Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Dry Eye Disease Price by Type (2018-2023) & (USD/Kg)
Table 25. Global Dry Eye Disease Sales by Type (2024-2034)
Table 26. Global Dry Eye Disease Revenue by Type (2024-2034) & (US$ Million)
Table 27. Global Dry Eye Disease Revenue Share by Type (2024-2034)
Table 28. Global Dry Eye Disease Price by Type (2024-2034) & (USD/Kg)
Table 29. Global Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 30. Global Dry Eye Disease Sales Share by Application (2018-2023)
Table 31. Global Dry Eye Disease Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Dry Eye Disease Price by Application (2018-2023) & (USD/Kg)
Table 33. Global Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 34. Global Dry Eye Disease Sales Share by Application (2024-2034)
Table 35. Global Dry Eye Disease Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Dry Eye Disease Revenue Share by Application (2024-2034)
Table 37. Global Dry Eye Disease Price by Application (2024-2034) & (USD/Kg)
Table 38. United States Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 39. United States Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 40. United States Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 42. United States Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 43. United States Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 44. United States Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 45. United States Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 46. United States Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 47. United States Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 48. United States Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 49. United States Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 50. Europe Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 51. Europe Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 52. Europe Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 54. Europe Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 55. Europe Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 56. Europe Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 57. Europe Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 58. Europe Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 59. Europe Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 60. Europe Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 61. Europe Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 62. China Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 63. China Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 64. China Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 66. China Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 67. China Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 68. China Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 69. China Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 70. China Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 71. China Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 72. China Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 73. China Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 74. Japan Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 75. Japan Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 76. Japan Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 78. Japan Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 79. Japan Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 80. Japan Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 81. Japan Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 82. Japan Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 83. Japan Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 84. Japan Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 85. Japan Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 86. Southeast Asia Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 87. Southeast Asia Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 91. Southeast Asia Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 93. Southeast Asia Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 94. Southeast Asia Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 95. Southeast Asia Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 97. Southeast Asia Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 98. India Dry Eye Disease Sales by Company (2018-2023) & (Kg)
Table 99. India Dry Eye Disease Sales Market Share by Company (2018-2023)
Table 100. India Dry Eye Disease Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Dry Eye Disease Revenue Market Share by Company (2018-2023)
Table 102. India Dry Eye Disease Sales by Type (2018-2023) & (Kg)
Table 103. India Dry Eye Disease Sales Market Share by Type (2018-2023)
Table 104. India Dry Eye Disease Sales by Type (2024-2034) & (Kg)
Table 105. India Dry Eye Disease Sales Market Share by Type (2024-2034)
Table 106. India Dry Eye Disease Sales by Application (2018-2023) & (Kg)
Table 107. India Dry Eye Disease Sales Market Share by Application (2018-2023)
Table 108. India Dry Eye Disease Sales by Application (2024-2034) & (Kg)
Table 109. India Dry Eye Disease Sales Market Share by Application (2024-2034)
Table 110. Santen Pharma Corporation Information
Table 111. Santen Pharma Description and Business Overview
Table 112. Santen Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. Santen Pharma Dry Eye Disease Product
Table 114. Santen Pharma Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Novartis Dry Eye Disease Product
Table 119. Novartis Recent Development
Table 120. Llergan Corporation Information
Table 121. Llergan Description and Business Overview
Table 122. Llergan Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Llergan Dry Eye Disease Product
Table 124. Llergan Recent Development
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Takeda Dry Eye Disease Product
Table 129. Takeda Recent Development
Table 130. TRB Chemedica Corporation Information
Table 131. TRB Chemedica Description and Business Overview
Table 132. TRB Chemedica Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 133. TRB Chemedica Dry Eye Disease Product
Table 134. TRB Chemedica Recent Development
Table 135. Sun Pharmaceutical Corporation Information
Table 136. Sun Pharmaceutical Description and Business Overview
Table 137. Sun Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 138. Sun Pharmaceutical Dry Eye Disease Product
Table 139. Sun Pharmaceutical Recent Development
Table 140. Senju Pharmaceutical Corporation Information
Table 141. Senju Pharmaceutical Description and Business Overview
Table 142. Senju Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 143. Senju Pharmaceutical Dry Eye Disease Product
Table 144. Senju Pharmaceutical Recent Development
Table 145. Sentiss Pharma Corporation Information
Table 146. Sentiss Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 147. Sentiss Pharma Description and Business Overview
Table 148. Sentiss Pharma Dry Eye Disease Product
Table 149. Sentiss Pharma Recent Development
Table 150. Johnson & Johnson Corporation Information
Table 151. Johnson & Johnson Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 152. Johnson & Johnson Description and Business Overview
Table 153. Johnson & Johnson Dry Eye Disease Product
Table 154. Johnson & Johnson Recent Development
Table 155. Otsuka Corporation Information
Table 156. Otsuka Description and Business Overview
Table 157. Otsuka Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 158. Otsuka Dry Eye Disease Product
Table 159. Otsuka Recent Development
Table 160. Mitotech Corporation Information
Table 161. Mitotech Description and Business Overview
Table 162. Mitotech Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 163. Mitotech Dry Eye Disease Product
Table 164. Mitotech Recent Development
Table 165. FCI Corporation Information
Table 166. FCI Description and Business Overview
Table 167. FCI Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 168. FCI Dry Eye Disease Product
Table 169. FCI Recent Development
Table 170. Altacor Corporation Information
Table 171. Altacor Description and Business Overview
Table 172. Altacor Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 173. Altacor Dry Eye Disease Product
Table 174. Altacor Recent Development
Table 175. Valeant Pharmaceuticals Corporation Information
Table 176. Valeant Pharmaceuticals Description and Business Overview
Table 177. Valeant Pharmaceuticals Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 178. Valeant Pharmaceuticals Dry Eye Disease Product
Table 179. Valeant Pharmaceuticals Recent Development
Table 180. United Laboratories Corporation Information
Table 181. United Laboratories Description and Business Overview
Table 182. United Laboratories Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 183. United Laboratories Dry Eye Disease Product
Table 184. United Laboratories Recent Development
Table 185. Jianfeng Group Corporation Information
Table 186. Jianfeng Group Description and Business Overview
Table 187. Jianfeng Group Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 188. Jianfeng Group Dry Eye Disease Product
Table 189. Jianfeng Group Recent Development
Table 190. Eusan GMBH Corporation Information
Table 191. Eusan GMBH Description and Business Overview
Table 192. Eusan GMBH Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 193. Eusan GMBH Dry Eye Disease Product
Table 194. Eusan GMBH Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Dry Eye Disease Distributors List
Table 198. Dry Eye Disease Customers List
Table 199. Dry Eye Disease Market Trends
Table 200. Dry Eye Disease Market Drivers
Table 201. Dry Eye Disease Market Challenges
Table 202. Dry Eye Disease Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Disease Product Picture
Figure 2. Global Dry Eye Disease Sales (US$ Million) by Type (2018 & 2024 & 2034)
Figure 3. Global Dry Eye Disease Sales Market Share by Type in 2024 & 2034
Figure 4. Artificial Tears Product Picture
Figure 5. Anti-inflammatory Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Dry Eye Disease Sales (US$ Million) by Application (2018 & 2024 & 2034)
Figure 8. Global Dry Eye Disease Sales Market Share by Application in 2024 & 2034
Figure 9. Hospital Examples
Figure 10. Drug Stores Examples
Figure 11. Online Pharmacies Examples
Figure 12. Global Dry Eye Disease Sales, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Dry Eye Disease Sales Growth Rate (2018-2034) & (US$ Million)
Figure 14. Global Dry Eye Disease Sales (Kg) Growth Rate (2018-2034)
Figure 15. Global Dry Eye Disease Price Trends Growth Rate (2018-2034) & (USD/Kg)
Figure 16. Global Market Dry Eye Disease Market Size (US$ Million) by Region:2018 VS 2024 VS 2034
Figure 17. Global Dry Eye Disease Revenue Market Share by Region: 2018 VS 2024
Figure 18. United States Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 19. United States Dry Eye Disease Sales (Kg) Growth Rate (2018-2034)
Figure 20. Europe Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 21. Europe Dry Eye Disease Sales (US$ Million) Growth Rate (2018-2034)
Figure 22. China Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 23. China Dry Eye Disease Sales (US$ Million) and Growth Rate (2018-2034)
Figure 24. Japan Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 25. Japan Dry Eye Disease Sales (US$ Million) Growth Rate (2018-2034)
Figure 26. Southeast Asia Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 27. Southeast Asia Dry Eye Disease Sales (US$ Million) Growth Rate (2018-2034)
Figure 28. India Dry Eye Disease Revenue (US$ Million) Growth Rate (2018-2034)
Figure 29. India Dry Eye Disease Sales (US$ Million) Growth Rate (2018-2034)
Figure 30. Global 5 Largest Dry Eye Disease Players Market Share by Revenue in Dry Eye Disease: 2018 & 2024
Figure 31. Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 32. Global Dry Eye Disease Revenue Share by Type (2018-2023)
Figure 33. Global Dry Eye Disease Sales Share by Type (2024-2034)
Figure 34. Global Dry Eye Disease Revenue Share by Type (2024-2034)
Figure 35. Global Dry Eye Disease Revenue Share by Application (2018-2023)
Figure 36. Global Dry Eye Disease Revenue Growth Rate by Application in 2018 & 2024
Figure 37. Global Dry Eye Disease Sales Share by Application (2024-2034)
Figure 38. Global Dry Eye Disease Revenue Share by Application (2024-2034)
Figure 39. Key Raw Materials Price Trend
Figure 40. Manufacturing Cost Structure of Dry Eye Disease
Figure 41. Manufacturing Process Analysis of Dry Eye Disease
Figure 42. Dry Eye Disease Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed